Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Polymer Transducers Revolutionize 3D Biomedical Imaging
Imaging & Diagnostics Polymer Transducers Revolutionize 3D Biomedical Imaging

A groundbreaking fusion of materials science and biomedical engineering is setting a new standard for medical imaging, promising to overcome the fundamental barriers of current technology to enable ultra-high-resolution, three-dimensional views of biological structures that were previously

Healthcare Cyberattacks Double Amid AI and Vendor Risks
Digital Health Healthcare Cyberattacks Double Amid AI and Vendor Risks

The healthcare sector finds itself in a precarious position, facing a relentless barrage of digital threats that have not only intensified but also strategically evolved to exploit the industry's most critical operational dependencies. An alarming surge in cyberattacks, coupled with the unregulated

Can AI Teams Learn to Think Like Doctors?
Patient Care Can AI Teams Learn to Think Like Doctors?

The immense pressure on modern healthcare systems, driven by workforce shortages and the complexities of value-based care, has created a critical need for solutions that move beyond simple automation. While initial forays into artificial intelligence offered tools like chatbots and basic data

European Voice Biomarker Market to Soar to $1.69 Billion
Digital Health European Voice Biomarker Market to Soar to $1.69 Billion

The subtle nuances within the human voice, long the domain of linguists and artists, are now being decoded by advanced algorithms to unlock a new frontier in medical diagnostics, positioning the European voice and vocal biomarker market for unprecedented expansion. This innovative sector of the

Senate Finds UnitedHealth Makes Patients Seem Sicker for Profit
Regulatory & Compliance Senate Finds UnitedHealth Makes Patients Seem Sicker for Profit

With a unique background in the systems and technology that underpin modern healthcare, James Maitland offers a critical perspective on the operational strategies of major health insurers. His work provides insight into how data and process optimization are used within complex regulatory

Can an AI Safely Refill Your Prescription?
Digital Health Can an AI Safely Refill Your Prescription?

The familiar and often frustrating process of securing a routine prescription refill, which can involve navigating appointment schedules and waiting days for a simple renewal, is being fundamentally challenged by a pioneering initiative in Utah. In a bold move to streamline healthcare, the state is

OpenAI Launches Private ChatGPT Health Assistant
Digital Health OpenAI Launches Private ChatGPT Health Assistant

In an age where personal health data is increasingly generated yet remains fragmented across countless apps and provider portals, the ability to form a coherent picture of one's own wellness has become a significant challenge. OpenAI has now stepped into this complex arena by launching ChatGPT

Are Hospitals Sacrificing Safety To Stay Afloat?
Infrastructure & Management Are Hospitals Sacrificing Safety To Stay Afloat?

A deepening financial crisis is pushing American hospitals to the brink, forcing them into a precarious balancing act between fiscal survival and their fundamental mission of patient care. Caught between the relentless rise of operational costs and reimbursement rates that fail to keep pace,

OpenAI Launches ChatGPT Health to Empower Patients
Digital Health OpenAI Launches ChatGPT Health to Empower Patients

Responding to a massive and deeply ingrained user trend that has been quietly unfolding for years, OpenAI has officially announced the launch of ChatGPT Health, a specialized AI platform designed to empower individuals in managing their personal health journey. The announcement, dated January 7,

FDA Eases Regulations for Health Software and Wearables
Patient Care FDA Eases Regulations for Health Software and Wearables

In a significant policy shift that reverberated through the technology and healthcare sectors, the U.S. Food and Drug Administration has substantially redefined its approach to regulating the burgeoning market of digital health tools. The updates, implemented on January 6, clarify the boundaries

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later